Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population
Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population
About this item
Full title
Author / Creator
Fernandez‐Diaz, Eva , Perez‐Vicente, Jose A. , Villaverde‐Gonzalez, Ramon , Berenguer‐Ruiz, Leticia , Candeliere Merlicco, Antonio , Martinez‐Navarro, Maria Luisa , Gracia Gil, Julia , Romero‐Sanchez, Carlos M. , Alfaro‐Saez, Arantxa , Diaz, Inmaculada , Gimenez‐Martinez, Juana , Mendez‐Miralles, Maria Angeles , Millan‐Pascual, Jorge , Jimenez‐Pancho, Javier , Mola, Santiago and Sempere, Angel P.
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Objective
Pivotal trial have shown that patients with multiple sclerosis (MS) receiving ocrelizumab had better outcomes. However, data on ocrelizumab in clinical practice are limited. The aim of this study was to evaluate the preliminary safety profile and effectiveness of ocrelizumab treatment for multiple sclerosis (MS) in a real‐world clinica...
Alternative Titles
Full title
Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population
Authors, Artists and Contributors
Author / Creator
Perez‐Vicente, Jose A.
Villaverde‐Gonzalez, Ramon
Berenguer‐Ruiz, Leticia
Candeliere Merlicco, Antonio
Martinez‐Navarro, Maria Luisa
Gracia Gil, Julia
Romero‐Sanchez, Carlos M.
Alfaro‐Saez, Arantxa
Diaz, Inmaculada
Gimenez‐Martinez, Juana
Mendez‐Miralles, Maria Angeles
Millan‐Pascual, Jorge
Jimenez‐Pancho, Javier
Mola, Santiago
Sempere, Angel P.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_36e53a30c73a4e0f8bca14d2d0533bc6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_36e53a30c73a4e0f8bca14d2d0533bc6
Other Identifiers
ISSN
2328-9503
E-ISSN
2328-9503
DOI
10.1002/acn3.51282
